Outcomes of rare patients with a primary cutaneous CD30(+) lymphoproliferative disorder developing extracutaneous disease

Rutger C. Melchers*, Rein Willemze, Joost S. P. Vermaat, Patty M. Jansen, Laurien A. Daniels, Hein Putter, Marcel W. Bekkenk, Ellen R. M. de Haas, Barbara Horvath, Michelle M. van Rossum, Cornelus J. G. Sanders, Joep C. J. M. Veraart, Maarten H. Vermeer, Koen D. Quint

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

8 Citations (Scopus)
46 Downloads (Pure)
Original languageEnglish
Pages (from-to)769-773
Number of pages6
JournalBlood
Volume135
Issue number10
DOIs
Publication statusPublished - 5-Mar-2020

Keywords

  • LARGE-CELL LYMPHOMA
  • BRENTUXIMAB VEDOTIN
  • PAPULOSIS
  • CLASSIFICATION
  • GUIDELINES
  • DIAGNOSIS
  • EORTC
  • ISCL

Cite this